Purchase Order 75N94022P00037
- Not listed
- This is a $10,417.90 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), an agency within the U.S. Department of Health and Human Services, to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey. The contract is for the provision of custom/monoclonal antibodies to support NICHD's biomedical research and public health initiatives. Genscript, which specializes in gene synthesis, protein production,...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), which is part of the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a small business biotechnology company based in Piscataway, New Jersey, for $11,434.95. The contract has an ultimate completion date of July 30, 2025. Genscript specializes in gene synthesis, gene editing, custom protein and antibody production, and other...
- This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $10,982.04 contract is for the provision of customized protein services, gene synthesis, and other molecular biology products and services to support biomedical research and public health initiatives. The contract does not...
- This federal contract award, valued at $4,367.10, was issued by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for a firm fixed-price purchase order with a completion date of September 30, 2014. Genscript, which operates as a for-profit organization, has received numerous prime and subcontract awards from various Department of Health and Human Services (HHS) agencies, including...
- This is a $14,500 firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services (HHS), to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey. The contract is for NICHD laboratory services and does not have a set-aside designation. Genscript is a provider of a wide range of molecular biology products and services to federal agencies, including gene...
- This federal contract award to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey, is for the provision of a wide range of molecular biology products and services to support biomedical research and public health initiatives. The $19,395.39 firm fixed-price purchase order contract, awarded by the National Institute of Child Health and Human Development (NICHD), covers gene synthesis, cloning, protein expression and purification, antibody production, and other...
- The National Institute of Child Health and Human Development (NICHD) awarded a Blanket Purchase Agreement (BPA) call order to GenScript USA Inc. valued at $24,500 on July 20, 2018, with an ultimate completion date of July 19, 2019. This firm fixed-price contract, which utilized no set-aside designation, represents a task order against an existing BPA vehicle and is to be performed in Bethesda, Maryland. GenScript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey,...
- This firm fixed-price purchase order, valued at $14,607.70, was awarded by the National Institute of Child Health and Human Development (NICHD) to Genscript USA Inc. for gene synthesis and cloning services. The ultimate completion date is August 29, 2024. Genscript is a biotechnology company based in Piscataway, New Jersey that specializes in molecular biology products and services to support biomedical research and public health initiatives for various federal agencies, including the National...
- GenScript USA Inc., a biotechnology company headquartered in Piscataway, New Jersey, received a Blanket Purchase Agreement (BPA) call order valued at $10,317.80 from the National Institute of Child Health and Human Development (NICHD) on August 28, 2018, with a completion date of September 28, 2018. The contract is structured as a firm fixed-price award with no set-aside designation. GenScript is a specialized vendor providing advanced molecular biology services, including gene synthesis, gene...
- The National Institutes of Health's National Institute of Child Health and Human Development awarded a $24,500 firm fixed price blanket purchase agreement call contract to Genscript USA Inc. of Piscataway, New Jersey. Under this contract, Genscript will provide custom gene synthesis services to NICHD in support of the Institute's research efforts. The contract has a period of performance of one year, from June 2023 through June 2024. It contains a total small business set-aside designation. No...
The National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, awarded a firm fixed-price purchase order contract worth $12,257.18 to Genscript USA Inc. for the provision of custom polyclonal antibodies. Genscript, a for-profit biotechnology company based in Piscataway, New Jersey, provides a range of molecular biology products and services to federal agencies, including gene synthesis, protein production, and antibody generation to support biomedical research and public health initiatives. This contract has a completion date of February 15, 2022 and was awarded on November 4, 2021. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from HHS agencies, including NIH, CDC, and FDA, as well as the USDA, to supply customized reagents and services for various research and development efforts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 2/14/22 | |
| Not listed | Not listed | $12.3k | 11/4/21 |